Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123727875 | 12372787 | 5 | F | 2016 | 20160714 | 20160516 | 20160725 | EXP | US-CELGENEUS-USA-2016053079 | CELGENE | 88.99 | YR | F | Y | 0.00000 | 20160725 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123727875 | 12372787 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | 10 MILLIGRAM | Y | U | A0560A | 21880 | 10 | MG | CAPSULES | QD | |||
| 123727875 | 12372787 | 2 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Subcutaneous | U | U | 0 | 40000 | IU | UNKNOWN | /wk | |||||
| 123727875 | 12372787 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 40000 IU (INTERNATIONAL UNIT) | 0 | UNKNOWN | |||||||||
| 123727875 | 12372787 | 4 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123727875 | 12372787 | 5 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123727875 | 12372787 | 6 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123727875 | 12372787 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123727875 | 12372787 | 1 | Plasma cell myeloma |
| 123727875 | 12372787 | 2 | Product used for unknown indication |
| 123727875 | 12372787 | 3 | Product used for unknown indication |
| 123727875 | 12372787 | 4 | Product used for unknown indication |
| 123727875 | 12372787 | 5 | Product used for unknown indication |
| 123727875 | 12372787 | 6 | Product used for unknown indication |
| 123727875 | 12372787 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123727875 | 12372787 | HO |
| 123727875 | 12372787 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123727875 | 12372787 | Drug hypersensitivity | |
| 123727875 | 12372787 | Full blood count decreased | |
| 123727875 | 12372787 | Haemoglobin decreased | |
| 123727875 | 12372787 | Herpes zoster | |
| 123727875 | 12372787 | Laboratory test abnormal | |
| 123727875 | 12372787 | Urinary tract infection | |
| 123727875 | 12372787 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123727875 | 12372787 | 1 | 20160416 | 20160703 | 0 |